TIRmed Pharma AB – Treat Immune Response

TIRmed Pharma AB – Treat Immune Response

TIRmed Pharma is developing a next generation topical treatment of eczema (atopic dermatitis) for mild to moderate symptoms. TIRmed Pharma´s product is a non-steroid cream that dampens inflammation and relieves itch.

Non-invasive and easy application
Regenerates the very tissue of the afflicted area
Saves vital immune defences

Our Solution

TIRmed Pharma’s immunomodulator selectively and rapidly inhibits certain innate immune responses. The approach represents a novel method to modulate immune responses and ameliorate itch.

The Product

TIRmed Pharma’s product is a cream and easy to use at-home anti-itch treatment. The product is intended for mild to moderate symptoms before the need of biologicals. TIRmed’s product is a next generation topical treatment without steroids.

Latest News

TIRmed Pharma raises 5.4 MSEK in equity to continue pursuing preclinical development of new antiviral treatment and a topical treatment for atopic eczema.

Eczema is a common disease affecting up to 20% of children and approximately 3% of adults, with a drugs market estimated up to 75 BSEK worldwide. The intense itch associated with the condition can lead to sleeping disorders, anxiety and depression. There is no cure as of today. The current treatments can ameliorate the symptoms…. Read more »

New publication

Amelioration of Compound 48/80-Mediated Itch and LL-37-Induced Inflammation by a Single-Stranded Oligonucleotide Authors: Aleksandra Dondalska, Elin Rönnberg, Haisha Ma, Sandra Axberg Pålsson, Elin Magnusdottir, Tianle Gao, Lucille Adam, Ethan A. Lerner , Gunnar Nilsson, Malin Lagerström and Anna-Lena Spetz Front. Immunol., 30 September 2020  https://doi.org/10.3389/fimmu.2020.559589